BIAL - Portela

Company snapshot

BIAL - Portela is a pharma organization headquartered in TROFA, PT. Primary therapeutic focus areas include No medical condition.. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (4).

• 4 active pipeline program(s) linked via ClinicalTrials.gov.
• 25 US patent(s) indexed to this assignee profile.
• 4 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for BIAL - Portela. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for BIAL - Portela.

1. Jun 8, 2026 Clinical update

   BLCL-AMC-03 — Phase 1

2. Jun 8, 2026 Clinical update

   BLCL-AMC-02 — Phase 1

3. Jun 8, 2026 Clinical update

   BLCL-AMC-01 — Phase 1

4. Jun 8, 2026 Clinical update

   BIA-28-6156-113 — Phase 1

5. May 21, 2026 Patent grant

   ANTAGONISTES DU RÉCEPTEUR DE L'ORÉXINE : COMPOSÉS 2-AZABICYCLIQUES

View all clinical trial activity →

• What is BIAL - Portela?

  BIAL - Portela is a pharma organization headquartered in TROFA, PT. Primary therapeutic focus areas include No medical condition.. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and US

• Is BIAL - Portela publicly traded?

  BIAL - Portela appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does BIAL - Portela develop or market?

  We link 9 drug profile(s) where BIAL - Portela is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/bial-portela-ca-eu#company-drugs.

• What are the latest developments for BIAL - Portela?

  In the last 12 months our linked public records show 4 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does BIAL - Portela focus on?

  BIAL - Portela focuses on No medical condition. based on our analysis of their pipeline programs and drug development activities.